APA (7th ed.) Citation

S, C., BG, Y., YI, M., SS, L., JC, Y., ZI, H., . . . AO, K. (2024). Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma. Journal of immunotherapy and precision oncology, 7(4), 255. https://doi.org/10.36401/JIPO-24-6

Chicago Style (17th ed.) Citation

S, Chamseddine, et al. "Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma." Journal of Immunotherapy and Precision Oncology 7, no. 4 (2024): 255. https://doi.org/10.36401/JIPO-24-6.

MLA (9th ed.) Citation

S, Chamseddine, et al. "Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma." Journal of Immunotherapy and Precision Oncology, vol. 7, no. 4, 2024, p. 255, https://doi.org/10.36401/JIPO-24-6.